AMGICIN(Gemcitabine)

AMGICIN(Gemcitabine)

Therapeutic class: Nucleoside Metabolic Inhibitor

  • Advanced ovarian cancer
  • Metastatic Breast Cancer
  • Non-Small Cell Lung Cancer.
  • Pancreatic cancer

- 200 mg & 1000 mg Injection
- Lyophilized single dose vial

- 20°C to 25°C (68°F to 77°F), Shelf Life: 2 Years

-As directed by physician

Copyright 2024. All right reserved